HS Icon Antisera and other blood fractions

300210 (Harmonized System 1992 for 6-digit)

World Trade (2018): $1.54B, Rnk 1572 / 4726

Top Exporter (2018): $373M, Germany

Top Importer (2018): $813M, Mexico

Product Complexity (2018): 1.03, Rnk 731 / 4873

Export Growth (CAGR)(2017 - 2018): -14%, Rnk 4408 / 4726

Mean Tariff (2018): 1.63%, Rnk 6281 / 6538

Share of World Trade (2018): 0.0084%, Rnk 1572 / 4726

Overview:  This page contains the latest trade data of Antisera and other blood fractions. In 2018, Antisera and other blood fractions were the world's 1572nd most traded product, with a total trade of $1.54B. Between 2017 and 2018 the exports of Antisera and other blood fractions decreased by -14%, from  $1.79B to $1.54B. Trade in Antisera and other blood fractions represent 0.0084% of total world trade.

Exports: In 2018 the top exporters of Antisera and other blood fractions  were Germany ($373M), United States ($358M), Switzerland ($182M), Mexico ($97.3M), and Spain ($80.7M).

Imports: In 2018 the top importers of Antisera and other blood fractions were Mexico ($813M), Saudi Arabia ($234M), Ukraine ($195M), Qatar ($91.1M), and United States ($68.9M).

Tariffs: In 2018 the average tariff for Antisera and other blood fractions was 1.63%, been the 6281 lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Antisera and other blood fractions are Romania (6.43%), Aruba (6%), Chad (4.9%), Uzbekistan (4.79%), and Laos (4.78%). The countries with the lowest tariffs are Egypt (0%), Ethiopia (0%), Mauritania (0%), Singapore (0%), and Ukraine (0%).

Ranking: Antisera and other blood fractions ranks 731st in the Product Complexity Index (PCI).

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): Germany, $373M

Top Destination (2018): Mexico, $813M

Antisera and other blood fractions are the world's 1572nd most traded product.

In 2018, the top exporters of Antisera and other blood fractions were Germany ($373M), United States ($358M), Switzerland ($182M), Mexico ($97.3M), and Spain ($80.7M).

In 2018, the top importers of Antisera and other blood fractions were Mexico ($813M), Saudi Arabia ($234M), Ukraine ($195M), Qatar ($91.1M), and United States ($68.9M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): Spain, $35.2M

Top Destination Growth (2017 - 2018): Saudi Arabia, $234M

Between 2017 and 2018, the exports of Antisera and other blood fractions grew the fastest in Spain ($35.2M), Belgium-Luxembourg ($11.7M), Ukraine ($11.5M), Denmark ($2.09M), and India ($1.97M).

Between 2017 and 2018, the fastest growing importers of Antisera and other blood fractions were Saudi Arabia ($234M), Mexico ($126M), Qatar ($91.1M), Ukraine ($44M), and Egypt ($21.7M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Antisera and other blood fractions.

In 2018,  market concentration measured using Shannon Entropy, was 3.48. This means that most of the exports of Antisera and other blood fractions are explained by 11 countries.

Explore Visualizations

TOP NET EXPORTER (2018): Germany, $372M

TOP NET IMPORTER (2018): Mexico, $716M

This map shows which countries export or import more of Antisera and other blood fractions. Each country is colored based on the difference in exports and imports of Antisera and other blood fractions during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Antisera and other blood fractions were Germany ($372M), United States ($289M), Switzerland ($181M), Spain ($80.1M), and Ireland ($63.8M).

In 2018, the countries that had a largest trade value in imports than in exports of Antisera and other blood fractions were Mexico ($716M), Saudi Arabia ($234M), Ukraine ($174M), Qatar ($91.1M), and Philippines ($24.5M).

Trade Forecasts

#permalink to section

This section shows forecasts for total trade for Antisera and other blood fractions. The forecast is based in a long short-term memory model or LSTM constructed using yearly trade data.

Explore Forecasts

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Antisera and other blood fractions was 1.63%.  The countries with the highest tariffs for importing Antisera and other blood fractions were Romania (6.43%), Aruba (6%), Chad (4.9%), Uzbekistan (4.79%), and Laos (4.78%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.